Cite
MLA Citation
Mario Campone et al.. “Cost of adverse events during treatment with everolimus plus exemestane or single-agent chemotherapy in patients with advanced breast cancer in Western Europe.” Journal of medical economics, vol. 17, 2014, pp. 837–845. http://access.bl.uk/ark:/81055/vdc_100089857425.0x00000a